Geftinat 250 mg (Gefitinib) is an oral anticancer medicine used primarily in the treatment of non-small cell lung cancer (NSCLC). It works by blocking the activity of tyrosine kinase, an enzyme responsible for cancer cell growth. For detailed medical insights, you can also refer to trusted resources like Mayo Clinic, Drugs.com, and the FDA.

Key Benefits & Uses

• Specifically designed for patients with advanced or metastatic NSCLC.

• Helps slow down or stop the growth of cancer cells.

• Improves survival outcomes and quality of life in EGFR mutation-positive patients.

• Backed by global studies available at PubMed and guidelines from the World Health Organization.

How to Use

• Geftinat 250 mg is usually taken once daily with or without food.

• Follow your doctor’s prescription carefully.

• Do not stop or adjust dosage without medical guidance. For additional patient-friendly advice, see WebMD and Healthline.

Important Safety Information

• Not suitable for patients with severe liver disease unless monitored closely.

• Inform your doctor about any allergies or prior lung conditions.

• Avoid use during pregnancy or breastfeeding.

• Always check with professional healthcare providers or resources like Mayo Clinic before use.

Common Side Effects

• Diarrhea

• Rash

• Nausea

• Loss of appetite

• Dry skin

Refer to Drugs.com or WebMD for a detailed list of side effects.

Why Choose Geftinat 250 mg

• Clinically proven to target EGFR mutation-positive lung cancer.

• Manufactured to international pharmaceutical standards.

• Recommended by oncologists worldwide.

• Supported by scientific research accessible at PubMed.